Highly Selective Aldose Reductase Inhibitors. II. Optimization of the Aryl Part of 3-(Arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic Acids
スポンサーリンク
概要
- 論文の詳細を見る
Accumulation of intracellular sorbitol, the product of glucose reduction catalyzed by aldose reductase (AR) [EC 1.1.1.21], is thought to be the main culprit in the development of diabetic complications. A series of 3-arylalkyl-2,4,5-trioxoimidazolidine-1-acetic acids was prepared and tested for inhibitory activities towards AR and aldehyde reductase (ALR) [EC 1.1.1.2]. These derivatives showed strong inhibitory activity against AR without markedly inhibiting ALR. In particular, the compounds with 3-nitrophenyl, 4-chloro-3-nitrophenyl, and chloro-substituted benzothiazolyl groups as the aryl part showed poweful AR-inhibitory activity. The chlorosubstituted benzothiazolyl compound showed an AR selectivity of more than 5000 fold.
- 公益社団法人日本薬学会の論文
- 1997-02-15
著者
-
Ishii A
Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd.
-
YAGO Hisashi
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co., Ltd.
-
OKAMOTO Kaoru
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co., Ltd.
-
Nagaki Yasuhiro
Institute Of Bio-active Science Nippon Zoki Pharmaceutical Company Ltd.
-
Yago Hisashi
Institute Of Bio-active Science Nippon Zoki Pharmaceutical Company Ltd.
-
Okamoto Kaoru
Institute Of Bio-active Science Nippon Zoki Pharmaceutical Company Ltd.
-
KOTANI Takayuki
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Company Ltd.,
-
ISHII Akira
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Company Ltd.,
-
TOYOMAKI Yoshio
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Company Ltd.,
-
SUEHIRO Seishi
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Company Ltd.,
-
OKUKADO Nobuhisa
Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Company Ltd.,
-
Suehiro Seishi
Institute Of Bio-active Science Nippon Zoki Pharmaceutical Company Ltd.
-
Okukado N
Institute Of Bio-active Science Nippon Zoki Pharmaceutical Company Ltd.
-
Kotani Takayuki
Institute Of Bio-active Science Nippon Zoki Pharmaceutical Company Ltd.
-
Toyomaki Y
Institute Of Bio-active Science Nippon Zoki Pharmaceutical Company Ltd.
-
Ishii Akira
Institute Of Bio-active Science Nippon Zoki Pharmaceutical Company Ltd.
関連論文
- Synthesis of Sialyllactose from N-Acetylneuraminic Acid and Lactose by a Neuraminidase from Arthrobacter ureafaciens
- A New Nonpeptide Tachykinin NK_1 Receptor Antagonist Isolated from the Plants of Compositae
- Highly Selective Aldose Reductase Inhibitors. II. Optimization of the Aryl Part of 3-(Arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic Acids